2026 RSV Access to Medicines PharmD Fellowship Program

Calla Lily Clinical Care, No Patient Left Behind, Pulmovant, Roivant Sciences, and Roivant Social Ventures (RSV), have partnered to create summer internship opportunities to provide real-world drug development experience to talented PharmD students. The intentions of this program are to expand access to medicines to vulnerable populations, and to further UNC Eshelman School of Pharmacy's goal of providing future industry leaders with pharmaceutical experience during their PharmD tenure.

We congratulate the following PharmD students on their 2026 internships and fellowships:

• Shane Brown, Roivant Sciences Research and Development Intern

• Ruhbani Jarral, Pulmovant Pharmacovigilance Intern

• Elainna Ng, RSV Global Access Fellow volunteering with Cally Lily Clinical Care in London, England. Calla Lily is transforming drug delivery for women through the development of their novel vaginal platform technology that supports fertility, pregnancy, and other gynaecological conditions.

• Nevaeh Roverato, RSV Access Fellow volunteering with No Patient Left Behind. No Patient Left Behind is a network of biotechnology innovators, investors, economists, healthcare professionals, and patients working together to support solutions that improve affordability while preserving the innovation ecosystem we all rely on.

The intentions of this program are to expand access to medicines to underserved populations, and to further UNC Eshelman School of Pharmacy's goal of providing future industry leaders with pharmaceutical experience during their PharmD tenure.